This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

3 New Investment Ideas From Greenlight's Einhorn

The hedge fund sold out its stake in drug giant Pfizer (PFE - Get Report) in the quarter, as it expects cuts in future government reimbursements for branded pharmaceuticals will hurt revenue. Also weighing on the shares are concerns about the recent disclosure of additional government investigations into Pfizer's marketing practices.

Also in the third quarter, Greenlight sold its stake in oil-industry giant BP (BP - Get Report) over fear of falling energy prices. The hedge fund ended a multiyear short position in Amedisys (AMED - Get Report), a home health and hospice company.

Einhorn spent a good part of the investors' letter eviscerating the business model and accounting methods of Green Mountain Coffee Roasters (GMCR - Get Report), in which his fund has a substantial short position. Green Mountain reports earnings after the close of trading today.

>>To see these stocks in action, visit the 3 New Investment Ideas From Greenlight's Einhorn portfolio on Stockpickr.

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.
3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
AMED $25.35 -5.50%
BP $43.34 -0.26%
CBS $62.61 -0.18%
GM $35.84 0.70%
GMCR $115.39 0.30%


DOW 18,070.17 -9.97 -0.06%
S&P 500 2,113.24 -4.45 -0.21%
NASDAQ 5,069.70 -22.3850 -0.44%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs